脊柱突肉瘤的治疗方法:对文献的全面审查
Aroosa Zamarud1, Syeda Shahnoor2, Adeena Maryyum3
11Department of Neurosurgery, Stanford University, School of Medicine, Stanford, California.
Journal of neurosurgery. Spine
|March 15, 2024
概括
立体射线手术 (SRS) 对脊柱突肉瘤 (SS) 具有前景,与传统治疗相比,提供更高的无进展和整体存活率. 这一综述有助于临床医生为脊柱SS患者选择最佳疗法.
科学领域:
- 在瘤学瘤学.
- 神经外科 神经外科
- 辐射疗法 辐射疗法
背景情况:
- 突肉瘤 (SS) 是一种罕见的软组织肉瘤,通常通过手术,放射和化疗进行治疗.
- 立体辐射手术 (SRS) 是对中枢神经系统 (CNS) 疾病的新兴治疗方法,但其在脊柱SS中的有效性尚未研究.
研究的目的:
- 系统地审查和分析脊柱突肉瘤 (SS) 的各种治疗方法的有效性.
- 具体评估立体性放射外科手术 (SRS) 在治疗脊柱SS的作用和结果.
主要方法:
- 对1964年至2022年间发表的研究进行了全面的PubMed搜索.
- 纳入标准集中在脊柱SS (原发性和转移性),成年患者 (≥17岁) 和英语研究,包括回顾系列和病例报告.
- 26项研究符合纳入标准,44项研究被排除在外.
主要成果:
- 分析了各种治疗方式,包括单独手术,用放射治疗 (RT) 和/或化疗进行手术,以及SRS.
- 用SRS治疗的患者的中位数无进展生存时间为37个月,总生存时间为60个月.
- 这些SRS生存指标明显高于其他治疗方法或组合观察到的生存指标.
结论:
- 本系统性审查提供了当前脊椎SS治疗策略的全面概述.
- 研究结果表明,SRS可能为脊柱SS患者提供更好的生存结果.
- 该研究旨在支持临床医生做出明智的治疗决策,以获得更好的患者预后.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524